Search
for
Sort by
Research 301–330 of 1000+
- Alopecia Areata: Current Treatments and New Directions
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Skin-specific expression of a truncated E1a oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation.
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- PKC downregulation upon rapamycin treatment attenuates mitochondrial disease
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Alopecia areata – Current understanding and management
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Mechanisms of autophagy and their implications in dermatological disorders
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
- Application of Marine Microbial Natural Products in Cosmetics
- Immune therapies for alopecia areata: evidence and new perspectives
- Biologics in the management of childhood atopic dermatitis
- Antioxidant Capacity and Protective Effect of Cow Placenta Extract on D-Galactose-Induced Skin Aging in Mice
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis